Persistence of Cardiac Remodeling in Preadolescents With Fetal Growth Restriction

Sebastian Imre Sarvari1, Merida Rodriguez-Lopez1, Marta Nuñez-Garcia1

  • 1From the Cardiology Department, Cardiovascular Institute, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain (S.I.S., M.S.); Department of Cardiology, Oslo University Hospital, Rikshospitalet, University of Oslo, Norway (S.I.S.); Fetal i+D Fetal Medicine Research Center, IDIBAPS (M.R.-L., A.S.-M., E.G., F.C.) and BCNatal | Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Déu (M.R.-L., A.S.-M., E.G., F.C.), Universitat de Barcelona, Spain; PhySense, Department of Information and Communication Technologies (DTIC), Universitat Pompeu Fabra, Barcelona, Spain (M.N.-G., O.C., C.B., B.B.); Centro de Investigación Biomédica en Red en Enfermedades Raras, Spain (E.G., F.C.); and ICREA, Barcelona, Spain (B.B.).

Insights

Fetal growth restriction (FGR) leads to lasting cardiac changes, including altered heart shape and function, persisting into preadolescence. These findings suggest primary cardiac programming contributes to adult cardiovascular risk in FGR individuals.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Developmental Biology

Background:

  • Fetal growth restriction (FGR) affects 5-10% of newborns.
  • FGR is linked to increased adult cardiovascular mortality.
  • Prenatal cardiovascular changes in FGR require further investigation into long-term effects.

Purpose of the Study:

  • To determine if cardiovascular changes observed in fetuses with FGR persist into preadolescence.
  • To investigate the long-term cardiac remodeling in individuals with a history of FGR.
  • To explore the link between FGR and lifelong cardiovascular health.

Main Methods:

  • A cohort study followed 58 FGR and 94 control individuals from fetus to preadolescence (8-12 years).
  • Echocardiography and 3D computational shape analysis were used to assess cardiac structure and function.
  • Statistical analysis adjusted for various confounding factors including parental ethnicity, smoking, and gestational age.

Main Results:

  • FGR preadolescents exhibited distinct cardiac shapes (more spherical, smaller hearts) compared to controls.
  • FGR individuals showed decreased longitudinal myocardial motion and impaired relaxation.
  • Global longitudinal strain was reduced in FGR, compensated by increased circumferential strain, with higher postsystolic shortening prevalence.

Conclusions:

  • Cardiac remodeling due to FGR persists into preadolescence, mirroring prenatal and childhood findings.
  • The study supports the hypothesis of primary cardiac programming in FGR.
  • These persistent cardiac alterations may explain the association between low birth weight and adult cardiovascular risk.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
699
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593